Decreased susceptibility to ceftriaxone in Neisseria gonorrhoeae in the absence of a mosaic penicillin-binding protein 2 (PenA) allele
S. Carroll, R. Kirkcaldy, J. Fox and 2 more
International Journal of Infectious Diseases · 2014
doi:10.1016/j.ijid.2014.03.639 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Background: In February, 2012, a 32 year old African American, heterosexual man in Oklahoma presented with gonorrhea exhibiting reduced susceptibility to ceftriaxone, with a minimum inhibitory concentration (MIC) of 0.5 μg/ml. No history of travel, drug use, or sex work was reported, and the individual denied having prior gonococcal infections. Methods & Materials: Whole genome sequencing of this isolate was performed using next-generation sequencing techniques (Roche 454 and Pacific Biosciences SMRT), and a suite of known gonococcal resistance determinants were examined to identify mutations potentially associated with reduced susceptibility to ceftriaxone. Results: The penicillin-binding protein 2 gene (penA) has been associated with both reduced susceptibility and treatment failure to the cephalosporins due to the presence of a mosaic penA allele; however, this particular isolate possessed a non-mosaic penA allele not normally associated with decreased susceptibility to cephalosporins. Conclusion: These results suggest that while a mosaic penA allele can be predictive for reduced susceptibility to cephalosporins in N. gonorrhoeae, it is not absolutely necessary. In this case, it appears that other mutations are responsible for the reduced susceptibility to ceftriaxone.
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.